These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37894280)

  • 21. Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study.
    Moretto R; Rossini D; Catteau A; Antoniotti C; Giordano M; Boccaccino A; Ugolini C; Proietti A; Conca V; Kassambara A; Pietrantonio F; Salvatore L; Lonardi S; Tamberi S; Tamburini E; Poma AM; Fieschi J; Fontanini G; Masi G; Galon J; Cremolini C
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37085190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Novel Predictive-Prognostic Scoring Index for Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer.
    Diker O; Olgun P; Balyemez U; Sigit Ikiz S
    Cureus; 2023 Jan; 15(1):e33234. PubMed ID: 36733552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.
    Furgiuele S; Descamps G; Lechien JR; Dequanter D; Journe F; Saussez S
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy.
    Yu A; Mansure JJ; Solanki S; Siemens DR; Koti M; Dias ABT; Burnier MM; Brimo F; Kassouf W
    PLoS One; 2018; 13(10):e0205746. PubMed ID: 30308033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
    Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
    Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel prognostic immunoscore based on The Cancer Genome Atlas to predict overall survival in colorectal cancer patients.
    Tang Z; Wu Y; Sun D; Xue X; Qin L
    Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34608935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.
    Kim KJ; Yang HK; Kim WH; Kang GH
    Oncotarget; 2017 Aug; 8(35):58887-58902. PubMed ID: 28938605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact of the tumor immune microenvironment in completely resected stage IIIA(N2) non-small cell lung cancer based on an immunoscore approach.
    Feng W; Li Y; Shen L; Zhang Q; Cai XW; Zhu ZF; Sun MH; Chen HQ; Fu XL
    Ther Adv Med Oncol; 2021; 13():1758835920984975. PubMed ID: 33488784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modified immunoscore improves the prediction of progression-free survival in patients with non-muscle-invasive bladder cancer: A digital pathology study.
    Bieri U; Enderlin D; Buser L; Wettstein MS; Eberli D; Moch H; Hermanns T; Poyet C
    Front Oncol; 2022; 12():964672. PubMed ID: 36212478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray.
    Gruber ES; Oberhuber G; Pils D; Stork T; Sinn K; Gruber S; Nica R; Kolmer D; Turner SD; Schlederer M; Widder J; Doerr W; Teleky B; Kenner L
    Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32121328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer.
    Boscolo A; Fortarezza F; Lunardi F; Comacchio G; Urso L; Frega S; Menis J; Bonanno L; Guarneri V; Rea F; Conte P; Calabrese F; Pasello G
    Front Oncol; 2020; 10():564915. PubMed ID: 33072595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform.
    Tang X; Xu P; Chen A; Deng G; Zhang S; Gao L; Dai L; Chen Q
    Front Genet; 2020; 11():514363. PubMed ID: 33244317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
    Santoni M; Buti S; Myint ZW; Maruzzo M; Iacovelli R; Pichler M; Kopecky J; Kucharz J; Rizzo M; Galli L; Büttner T; De Giorgi U; Kanesvaran R; Fiala O; Grande E; Zucali PA; Kopp RM; Fornarini G; Bourlon MT; Scagliarini S; Molina-Cerrillo J; Aurilio G; Matrana MR; Pichler R; Cattrini C; Büchler T; Massari F; Seront E; Calabrò F; Pinto A; Berardi R; Zgura A; Mammone G; Ansari J; Atzori F; Chiari R; Bamias A; Caffo O; Procopio G; Sunela K; Bassanelli M; Ortega C; Grillone F; Landmesser J; Milella M; Messina C; Küronya Z; Mosca A; Bhuva D; Santini D; Vau N; Morelli F; Incorvaia L; Rebuzzi SE; Roviello G; Soares A; Bisonni R; Bimbatti D; Zabalza IO; Rizzo A; Mollica V; Sorgentoni G; Monteiro FSM; Battelli N; Bracarda S; Porta C
    Eur Urol Oncol; 2024 Feb; 7(1):102-111. PubMed ID: 37481365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.
    Pagès F; André T; Taieb J; Vernerey D; Henriques J; Borg C; Marliot F; Ben Jannet R; Louvet C; Mineur L; Bennouna J; Desrame J; Faroux R; Kirilovsky A; Duval A; Laurent-Puig P; Svrcek M; Hermitte F; Catteau A; Galon J; Emile JF
    Ann Oncol; 2020 Jul; 31(7):921-929. PubMed ID: 32294529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiles for a prognostic immunoscore in gastric cancer.
    Zeng D; Zhou R; Yu Y; Luo Y; Zhang J; Sun H; Bin J; Liao Y; Rao J; Zhang Y; Liao W
    Br J Surg; 2018 Sep; 105(10):1338-1348. PubMed ID: 29691839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Immunoscore in Colorectal Carcinomas.
    Imen H; Amira H; Fatma K; Raja J; Mariem S; Haithem Z; Ehsene BB; Aschraf C
    Int J Surg Pathol; 2024 Feb; 32(1):58-65. PubMed ID: 37097904
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
    Mlecnik B; Torigoe T; Bindea G; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Hirohashi Y; Furuhata T; Takemasa I; Patel P; Vora H; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Yoshino T; Taniguchi H; Bifulco C; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson E; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Marliot F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; Van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Marincola FM; Ascierto PA; Fox BA; Pagès F; Kawakami Y; Galon J
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
    Li Y; Brendel M; Wu N; Ge W; Zhang H; Rietschel P; Quek RGW; Pouliot JF; Wang F; Harnett J
    Sci Rep; 2022 Oct; 12(1):17670. PubMed ID: 36271096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
    Mlecnik B; Lugli A; Bindea G; Marliot F; Bifulco C; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; Vliet SVL; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Patel P; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.